[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

Pdl Biopharma Inc (PDLI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2008	12-2007	09-2007	06-2007	03-2007
Assets
Current Assets
Cash & Cash Equivalents	920,666	365,639	235,008	230,412	167,549
Marketable Securities	22,973	71,880	141,238	147,735	158,501
Receivables	5,846	5,163	9,321	11,113	14,338
Inventories	N/A	N/A	26,927	25,030	20,483
Other current assets	0	270,400	20,621	0	0
TOTAL	$961,824	$720,434	$443,980	$424,174	$372,428

Non-Current Assets
PPE Net	134,550	330,746	329,520	334,721	305,889
Investments And Advances	0	3,269	29,972	54,905	75,000
Intangibles	8,644	90,780	341,103	350,681	347,293
Other Non-Current Assets	12,596	46,963	18,819	19,408	20,071
TOTAL	$155,790	$471,758	$719,414	$759,715	$748,253

Total Assets	$1,117,614	$1,192,192	$1,163,394	$1,183,889	$1,120,681

Liabilities
Current Liabilities
Short Term Debt	735	678	6,320	658	N/A
Accounts payable and accrued liabilities	3,078	8,893	4,909	20,386	5,383
Accrued Expenses	26,602	33,189	26,037	22,633	26,106
Other current liabilities	N/A	N/A	N/A	N/A	646
TOTAL	$79,333	$122,088	$89,650	$102,124	$84,270

Non-Current Liabilities
Long Term Debt	N/A	N/A	32,143	N/A	N/A
Deferred Revenues	8,197	7,171	7,171	7,171	10,024
Other Non-Current Liabilities	531,845	534,847	499,998	536,107	536,372
TOTAL	$559,658	$562,494	$561,885	$567,757	$569,701

Total Liabilities	$638,991	$684,582	$651,535	$669,881	$653,971

Shareholders' Equity
Shares Outstanding, K	119,308	117,668	117,105	116,831	116,604
Common Shares	1,181	1,176	1,172	1,169	1,154
Retained earnings	-653,220	-591,345	-575,766	-564,964	-580,890
Other shareholders' equity	-371	-472	-765	-955	-1,066
TOTAL	$478,623	$507,610	$511,859	$514,008	$466,710

Total Liabilities And Equity	$1,117,614	$1,192,192	$1,163,394	$1,183,889	$1,120,681